Longeveron Inc.
Biotechnology · MIAMI, FL
BiotechnologySEC Form D
Longeveron Inc. filed a Form D with the U.S. Securities and Exchange Commission on March 25, 2026, reporting $15,890,000 raised toward a $33,515,000 offering.
Incorporated in Delaware and based in MIAMI, FL, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Longeveron Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Stephen H. WillardExecutive Officer
- Joshua M. HareExecutive Officer · Director
- Lisa A. LocklearExecutive Officer
- Nataliya AgafonovaExecutive Officer
- Paul LehrExecutive Officer
- Devin BlassExecutive Officer
- Rock SofferDirector
- Ursula UngaroDirector
- Roger Joseph HajjarDirector
- George Paletta, Jr.Director
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised